-
Henry Schein Medical Announces Availability of VisualDx
Apr 13, 2020, 12:24 PM by Michael CroftMELVILLE, NY, UNITED STATES - Apr 13, 2020 - Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., announced today the availability of VisualDx to assist health care professionals seeing patients virtually or in person amid the novel COVID-19 outbreakFull story -
Training Scientists For Our Interdisciplinary Future
Apr 13, 2020, 08:40 AM by Michael CroftFull storyBio-IT World | TRENDS FROM THE TRENCHES | Interdisciplinary research is continuously lauded as a key to making progress in the life sciences and healthcare. But such approaches come with some particular organizational demands.
-
TGen, Amgen, CeMM, And More: Bio-IT Community Rallies Against COVID-19
Apr 10, 2020, 12:45 PM by Michael CroftFull storyBio-IT World | The SARS-CoV-2 virus is serving as a rallying cry across the bio-IT landscape inspiring creative new solutions, partnerships, and ideas to address the outbreak, treat and prevent the disease it causes, and address the life adjustments of our new normal.
-
COVID-19 Datasets Bring AI Experts, Life Sciences Researchers Together For A Cure
Apr 10, 2020, 08:25 AM by Michael CroftFull storyBio-IT World | The Bio-IT community is eager to contribute to plans for treatments, diagnostics and vaccines for COVID-19, donating consulting services, compute resources, tools for clinical trials, and so much more. But the biggest donations might be the sheer volume of data being pooled for researchers to mine for answers.
-
Greenphire Launches Extension of its ConneX Solution, ConneX Patient Direct, as Trial Sites Seek Support in Response to COVID-19
Apr 8, 2020, 11:21 AM by Michael CroftKING OF PRUSSIA, PA, UNITED STATES - Apr 8, 2020 - Greenphire, the global leader in financial software for clinical trials, today announced the launch of its ConneX Patient Direct service to enable global clinical trial sites to continue their critical work and patient support in an effort to offset the impact of COVID-19Full story -
ZEISS Lightsheet 7 Allows Multiview Imaging of Both Living and Cleared Specimens
Apr 8, 2020, 11:17 AM by Michael CroftJENA, GERMANY - Apr 8, 2020 - Light sheet fluorescence microscopy (LSFM) with its unique illumination principle allows fast and gentle imaging of whole living model organisms, tissues, and developing cellsFull story -
Sinequa Launches Free COVID Intelligent Insight
Apr 7, 2020, 10:35 AM by Michael CroftBio-IT World In an open letter to the scientific medical community yesterday, Alexandre Bilger, CEO at Sinequa, announced COVID Intelligent Insight, an open, free, and collaborative scientific search portal to gather the most useful and relevant information related to the virus.Full story -
Coronavirus Solutions: High Performance Computing, Testing, Clinical Trials Tools, Nursing Solutions, and More
Apr 6, 2020, 17:45 PM by Michael CroftBio-IT World | The biotech and life sciences communities are rallying around the scientific challenges presented by the novel coronavirus pandemic. Here we gather the latest efforts, updates and tools made available to and for the bio-IT community including the updated SARS-CoV-2 genome browser, COVID-19 High Performance Computing Consortium, BGI’s testing efforts in Israel, Sema4’s testing efforts in New York and Connecticut, and more.Full story -
Independent Site Management Organisation Panthera prepares for COVID-19
Apr 6, 2020, 16:25 PM by Michael CroftPRESTON, UNITED KINGDOM - Apr 6, 2020 - The safety of clinical trial patients and staff is paramount. We are working with our clients in pharma and CROs to assess each trial to see if it needs to be suspended, delayed or if it can carry on in a way that is safe both for the clinicians and participants commented Stuart Young CEO of Panthera the independent SMOFull story -
Clareto Announces Partnership with Diameter Health to Streamline Insurance Processes
Apr 6, 2020, 11:13 AM by Michael CroftRICHMOND, VA, UNITED STATES - Apr 6, 2020 - Clareto, an innovator in acquiring electronic health data for insurance underwriting and claims processes, today announced its partnership with Diameter Health, developer of the leading platform for clinical data normalization and enhancementFull story -
CluePoints Launches Complimentary COVID-19 Risk Management Package for Clinical Studies
Apr 6, 2020, 11:12 AM by Michael CroftKING OF PRUSSIA, PA, US - Apr 6, 2020 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that it has launched a complimentary COVID-19 risk management package available to all at no costFull story -
BioIVT Opens New Blood Donor Center to Support Boston-area Research into COVID-19 Therapies, Vaccines and Diagnostics
Apr 6, 2020, 08:13 AM by Michael CroftWESTBURY, NY - Apr 6, 2020 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the opening of its new blood donor center on the Tufts University campus in Medford, MA to support academic and pharmaceutical researchers involved in COVID-19, cell and gene therapy researchFull story -
AgileBio Launches a LIMS Package Addressed to COVID-19 Labs
Apr 3, 2020, 17:50 PM by Michael CroftSAN DIEGO, CA, US - Apr 3, 2020 - AgileBio, a leading global provider of LabCollector LIMS solution that enhances research, testing & traceability to scientist teams announces new COVID LabCollector + Lab Service Management (LSM) Pack that will increase the speed and efficiency in COVID-19 tests managementFull story -
Spring Bank Provides Update on Business Operations & Clinical Program Progress During COVID-19 Pandemic
Apr 3, 2020, 10:17 AM by Michael CroftHOPKINTON, MA, UNITED STATES - Apr 2, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today provided an update on the companys business operations in response to and as a result of the global COVID-19 pandemicFull story -
The American Hospital Association and AVIA Launch New Tool to Support Members on the Front Lines of the COVID-19 Crisis: Introducing the COVID-19 Digital Response Pulse
Apr 2, 2020, 10:18 AM by Michael CroftCHICAGO, IL, UNITED STATES - Apr 2, 2020 - Today, the American Hospital Association (AHA) & AVIA are reaching out to all AHA members with a new tool for rapid, critical support to deal with COVID-19Full story -
Seqster, Pryzm, Apple Tracking Symptoms, Spread, And Coronavirus Data
Apr 2, 2020, 09:40 AM by Michael CroftBio-IT World Last week, several groups released COVID-19 screening tools or symptom checkers to help track the spread of the virus, help people make decisions about when to receive care, and track trends. Apple and Seqster both launched symptom trackers in the United States. Covidaware.me launched internationally to track symptoms and share data, and the TwinsUK study launched a COVID-19 symptom tracker and research study using a cohort of twins.Full story -
AmoTx Now Offers Face Masks and PPE During Coronavirus Pandemic
Apr 2, 2020, 03:44 AM by Michael CroftNY, NY, UNITED STATES - Apr 2, 2020 - The medical device provider AmoTx is now openly offering face masks for people in Europe and North AmericaFull story -
InSysBio to announce the release of its new database Cytocon DB 1.1
Apr 1, 2020, 09:27 AM by Michael CroftMOSCOW, RUSSIA - Apr 1, 2020 - InSysBio, one of the worlds pioneers of Quantitative Systems Pharmacology (QSP) platform development and provision, has released its new Cytocon DB 1Full story -
PHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical Trials
Apr 1, 2020, 08:20 AM by Michael CroftNOTTINGHAM, UK - Apr 1, 2020 -Full storyPHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical TrialsNottingham, UK - 01 April 2020: PHARMASEAL International, provider of clinical trials management systems has today announced that it will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus clinical trialsx
-
Optibrium and Intellegens achieve further success in Open Source Malaria initiative with in vitro validation of in silico generated compound
Apr 1, 2020, 05:23 AM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Apr 1, 2020 - Optibrium, leading providers of software and services for drug discovery, and Intellegens, a spin-out from the University of Cambridge with a unique Artificial Intelligence (AI) toolset, today announced they have reached a further significant milestone in their contribution to the Open Source Malaria (OSM) initiativeFull story